China's Bio-Thera Solutions Partners with Cipla to Market Key Cancer Biosimilar

Immunocore Names Jallal as CEO

Pfizer commences alopecia areata phase 2b/3 clinical trial

Banner Receives FDA Tentative Approval for Bafiertam for the Treatment of Relapsing Forms of Multiple Sclerosis

Banner granted FDA tentative approval for BAFIERTAM to treat relapsing forms of multiple sclerosis

US FDA Clears Precigen IND to Initiate Phase 1/1b Study for First-in-Class PRGN-3006 UltraCAR-T Therapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndrome

I-Mab Receives US FDA IND Approval for Proprietary Anti-GM-CSF Monoclonal Antibody TJM2

Bio-Thera Solutions Files China IND for Phase 1 Clinical Trial with BAT8003 (Trop2-ADC) as Treatment for Trop2 Positive Cancers

US FDA approves I-Mab's IND for TJM2

USFDA approves I-Mab Biopharma's Investigational New Drug for TJM2

FDA Approves US Merck's Keytruda for the Treatment of Adult and Pediatric Patients with Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma, a Rare form of Skin Cancer

Annexon Biosciences Closes USD 75m Financing

Compass Therapeutics Names Chief Medical officer and Chief Financial Officer

Fuji Pharma acquires 4.2% share in Alvotech

Amgen awarded the US FDA approval for Nplate (Romiplostim) for the treatment of immune thrombocytopenia in paediatric patients